Pfizer released an early snapshot of its Phase 3 trials for its coronavirus vaccine on Monday, and said the results look promising with data suggesting it’s 90 per cent effective at preventing the virus.The company and its collaborator BioNTech may now be on track to file an emergency use application with U.S.
regulators in late November, as previously stated. Pfizer’s coronavirus vaccine may be 90% effective, early data suggests However, the announcement does not mean a vaccine is fast approaching, experts warn.“We aren’t doing terribly well in the fight against COVID-19.
The numbers just keep rising in Canada and around the world,” said Kerry Bowman, a professor of bioethics and global health at the University of Toronto.“This is.